Q J Med 1994; 87: 403-406
© 1994 Association of Physicians
research-article |
Factor VII activity and ischaemic heart disease: fatal and non-fatal events
MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, The Medical College of St Bartholomew's Hospital London, UK
Address correspondence to Professor T.W. Meade, MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, The Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ
Received 29 March 1994 Accepted for publication 13 July 1994.
The Northwick Park Heart Study suggested that factor VII activity might be more strongly related to fatal than non-fatal events of ischaemic heart disease. We used polychotomous logistic regression to model simultaneously the probabilities of fatal events, non-fatal myocardial infarction, dying of causes other than ischaemic heart disease and of event-free survival. We followed 1459 white men aged 40–64 at recruitment for a mean period of 16.1 years. Of these, 92 died of ischaemic heart disease, 100 experienced non-fatal myocardial infarction, 173 died of other causes, and 1094 men were alive. Factor VII activity was strongly related to fatal events of ischaemic heart disease but not to non-fatal events (p=0.008). A difference of 1 SD in factor VII activity was associated with a difference of nearly 50% in the probability of dying of ischaemic heart disease, but with no difference for non-fatal myocardial infarction. This contrast was not seen for smoking, cholesterol, blood pressure, fibrinogen or factor VIII activity. High levels of VII activity may influence outcome at the time of plaque rupture and tissue factor release by enhancing thrombin production and thus fibrin deposition and platelet aggregability. The apparently differential effect of factor VII activity on fatal and non-fatal ischaemic heart disease may have important screening and prophylactic implications.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Mikkelsson, M. Perola, and P. J. Karhunen Genetics of Platelet Glycoprotein Receptors: Risk of Thrombotic Events and Pharmacogenetic Implications Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 113 - 125. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Zitzmann, R. Junker, A. Kamischke, and E. Nieschlag Contraceptive Steroids Influence the Hemostatic Activation State in Healthy Men J Androl, July 1, 2002; 23(4): 503 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Catto Genetic aspects of the hemostatic system in cerebrovascular disease Neurology, September 1, 2001; 57(90002): S24 - 30. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Pinotti, R. Toso, D. Girelli, D. Bindini, P. Ferraresi, M. L. Papa, R. Corrocher, G. Marchetti, and F. Bernardi Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies Blood, June 1, 2000; 95(11): 3423 - 3428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Larsen, J. Jespersen, and P. Marckmann Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently Am. J. Clinical Nutrition, December 1, 1999; 70(6): 976 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. I Mennen, M. P. de Maat, G. Meijer, P. Zock, D. E Grobbee, F. J Kok, C. Kluft, and E. G Schouten Postprandial response of activated factor VII in elderly women depends on the R353Q polymorphism Am. J. Clinical Nutrition, October 1, 1999; 70(4): 435 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Moss, R. E. Goldstein, V. J. Marder, C. E. Sparks, D. Oakes, H. Greenberg, H. J. Weiss, W. Zareba, M. W. Brown, C.-S. Liang, et al. Thrombogenic Factors and Recurrent Coronary Events Circulation, May 18, 1999; 99(19): 2517 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. Mennen, M. P. M. de Maat, E. G. Schouten, C. Kluft, J. C. M. Witteman, A. Hofman, and D. E. Grobbee Dietary Effects on Coagulation Factor VII Vary across Genotypes of the R/Q353 Polymorphism in Elderly People J. Nutr., May 1, 1998; 128(5): 870 - 874. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Mennen, M. de Maat, G. Meijer, P. Zock, D. Grobbee, F. Kok, C. Kluft, and E. Schouten Factor VIIa Response to a Fat-Rich Meal Does Not Depend on Fatty Acid Composition : A Randomized Controlled Trial Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 599 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bernardi, P. Arcieri, R. M. Bertina, F. Chiarotti, J. Corral, M. Pinotti, H. Prydz, M. Samama, P. M. Sandset, R. Strom, et al. Contribution of Factor VII Genotype to Activated FVII Levels : Differences in Genotype Frequencies Between Northern and Southern European Populations Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2548 - 2553. [Abstract] [Full Text]
|
|
|
|
|
|
M. P.M. de Maat, F. Green, P. de Knijff, J. Jespersen, and C. Kluft Factor VII Polymorphisms in Populations With Different Risks of Cardiovascular Disease Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1918 - 1923. [Abstract] [Full Text]
|
|
|
|
 |
|
 Randomised comparison of oestrogen versus oestrogen plus progestogen hormone replacement therapy in women with hysterectomy BMJ, February 24, 1996; 312(7029): 473 - 478. [Abstract] [Full Text]
|
|